Clinical Trial Update: A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

A Phase I safety and pharmacokinetic study of intravenously administered Gamitrinib in patients with advanced cancer is ongoing, including lymphoma and other so…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• Gamitrinib (Gamitrinib)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Lymphoma, Advanced Solid Tumor | Phase 1 | Status: RECRUITING